CARB-X LAUNCHES NEW FUNDING ROUND TO FILL MAJOR R&D GAPS IN GLOBAL PIPELINE

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today a funding solicitation with four distinct product themes:

• THERAPEUTICS FOR INFECTIONS CAUSED BY GRAM-NEGATIVE PATHOGENS
• PREVENTION FOR INVASIVE DISEASE
• DIAGNOSTICS FOR NEONATAL SEPSIS
• PROOF-OF-CONCEPT FOR NOVEL SAMPLE TYPES FOR DIAGNOSING LOWER-RESPIRATORY-TRACT INFECTIONS
  
  

Target product profiles and minimal acceptable criteria for all funding calls will be defined and available on carb-x.org.

Expressions of interest for all themes may be submitted during these timeframes:

• 18 March 2024 at 10:00 ET – 29 March 2024 at 23:59 ET
• 23 September 2024 at 10:00 ET – 4 October 2024 at 23:59 ET